4.8 News Item

A Case for a Human Immuno-Peptidome Project Consortium

Journal

IMMUNITY
Volume 47, Issue 2, Pages 203-208

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2017.07.010

Keywords

-

Categories

Funding

  1. HUPO
  2. Ludwig Cancer Research
  3. Swiss National Science Foundation
  4. SystemsX
  5. Swiss Cancer League
  6. eLife Scientific Publications
  7. Genentech
  8. Novartis
  9. Roche
  10. Biognosys
  11. Merck
  12. ThermoFisher Scientific
  13. EC HOR2020 project TBVAC2020 [2-73838-14]

Ask authors/readers for more resources

A multidisciplinary group of researchers gathered at the Honggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (https://hupo.org/human-immunopeptidome-project/). The long-term goal of this project is to map the entire repertoire of peptides presented by human leukocyte antigen molecules using mass spectrometry technologies, and make its robust analysis accessible to any immunologist. Here we outline the specific challenges identified toward this goal, and within this framework, describe the structure of a multipronged program aimed at addressing these challenges and implementing solutions at a community-wide level. Pillars of that program are: (1) method and technology development, (2) standardization, (3) effective data sharing, and (4) education. If successful, this community-driven endeavor might provide a roadmap toward new paradigms in immunology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available